These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26181913)

  • 1. Prostate Cancer Diagnosis Using MR/Ultrasound-Fusion Guided Biopsy: Ending the "Needle in a Haystack" Conundrum?
    Tombal BF; Van Nieuwenhove S; Lecouvet FE
    JAMA Oncol; 2015 Sep; 1(6):831-2. PubMed ID: 26181913
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
    Gershman B; Karnes RJ
    Eur Urol; 2015 Sep; 68(3):536-7. PubMed ID: 26282353
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer.
    Taneja SS
    J Urol; 2015 Jul; 194(1):112-5. PubMed ID: 26088222
    [No Abstract]   [Full Text] [Related]  

  • 4. Words of Wisdom. Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-guided Biopsy for the Diagnosis of Prostate Cancer.
    Walz J
    Eur Urol; 2016 Apr; 69(4):756-7. PubMed ID: 26972500
    [No Abstract]   [Full Text] [Related]  

  • 5. MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?
    Schwartz LH; Basch E
    JAMA; 2015 Jan; 313(4):367-8. PubMed ID: 25626034
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer: MR-TRUS fusion biopsy--defining a new standard.
    Klein EA
    Nat Rev Clin Oncol; 2015 May; 12(5):253-4. PubMed ID: 25869459
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: first round of targeted biopsies with magnetic resonance imaging/ ultrasound-fusion images compared to conventional ultrasound-guided trans-rectal biopsies for the diagnosis of localised prostate cancer.
    Taneja SS
    J Urol; 2014 Jul; 192(1):127-8. PubMed ID: 25625151
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted biopsy with MRI and ultrasound improves detection of high risk prostate cancer.
    Mayor S
    BMJ; 2015 Jan; 350():h472. PubMed ID: 25630373
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
    Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
    BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision curve analysis.
    Fitzgerald M; Saville BR; Lewis RJ
    JAMA; 2015 Jan; 313(4):409-10. PubMed ID: 25626037
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy.
    Bjurlin MA; Taneja SS
    Urol Clin North Am; 2017 Nov; 44(4):535-546. PubMed ID: 29107270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
    Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
    Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
    Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
    BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Words of wisdom. Re: Improving detection of clinically significant prostate cancer: MRI/TRUS fusion-guided prostate biopsy.
    Villers A
    Eur Urol; 2014 Jun; 65(6):1218-9. PubMed ID: 24774825
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
    Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
    Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging fusion in the diagnosis of prostate cancer].
    Zhang YY; Hu B; Chen L
    Zhonghua Nan Ke Xue; 2015 Jan; 21(1):78-81. PubMed ID: 25707146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Prostate Cancer Grade Groups Are Detected in Patients Undergoing Multiparametric MRI-targeted Biopsy Compared With Standard Biopsy.
    Gordetsky JB; Thomas JV; Nix JW; Rais-Bahrami S
    Am J Surg Pathol; 2017 Jan; 41(1):101-105. PubMed ID: 27574875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.